ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 23 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,286 | +15.7% | 1,073 | +3.9% | 0.00% | – |
Q2 2023 | $10,619 | +88391.7% | 1,033 | -31.1% | 0.00% | – |
Q1 2023 | $12 | +50.0% | 1,499 | +46.8% | 0.00% | – |
Q4 2022 | $8 | -99.9% | 1,021 | -36.3% | 0.00% | – |
Q3 2022 | $12,000 | -93.3% | 1,604 | -92.4% | 0.00% | -100.0% |
Q2 2022 | $180,000 | +900.0% | 21,209 | +958.3% | 0.00% | – |
Q1 2022 | $18,000 | +63.6% | 2,004 | +148.9% | 0.00% | – |
Q4 2021 | $11,000 | -47.6% | 805 | -59.5% | 0.00% | -100.0% |
Q3 2021 | $21,000 | +200.0% | 1,988 | +178.4% | 0.00% | – |
Q2 2021 | $7,000 | -30.0% | 714 | -28.2% | 0.00% | – |
Q1 2021 | $10,000 | +150.0% | 995 | +243.1% | 0.00% | – |
Q4 2020 | $4,000 | -96.7% | 290 | -97.9% | 0.00% | -100.0% |
Q3 2020 | $120,000 | +5900.0% | 13,645 | +7609.0% | 0.00% | – |
Q2 2020 | $2,000 | – | 177 | +98.9% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 89 | -85.9% | 0.00% | – |
Q1 2019 | $4,000 | -63.6% | 633 | -78.9% | 0.00% | -100.0% |
Q4 2018 | $11,000 | +37.5% | 2,995 | +138.6% | 0.00% | 0.0% |
Q3 2018 | $8,000 | -20.0% | 1,255 | -6.1% | 0.00% | 0.0% |
Q2 2018 | $10,000 | +900.0% | 1,337 | +1292.7% | 0.00% | – |
Q1 2018 | $1,000 | -90.0% | 96 | -89.2% | 0.00% | -100.0% |
Q4 2017 | $10,000 | – | 885 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |